IIM
IBRX icon

INTECH Investment Management’s ImmunityBio IBRX Stock Holding History

INTECH Investment Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Sell
78,218
-2,770
-3% -$21K 0.01% 1199
2026
Q1 		$621K Sell
80,988
-28,174
-26% -$193K 0.01% 1240
2025
Q4 		$216K Sell
109,162
-9,047
-8% -$20.5K ﹤0.01% 1943
2025
Q3 		$291K Sell
118,209
-47,710
-29% -$123K ﹤0.01% 1840
2025
Q2 		$438K Buy
165,919
+33,960
+26% +$91.3K ﹤0.01% 1684
2025
Q1 		$397K Buy
131,959
+26,573
+25% +$80.5K ﹤0.01% 1741
2024
Q4 		$270K Buy
105,386
+37,246
+55% +$155K ﹤0.01% 1884
2024
Q3 		$253K Buy
+68,140
New +$315K ﹤0.01% 1609

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

INTECH Investment Management's IBRX Position: Q2 2026 in Review

INTECH Investment Management reduced its ImmunityBio (IBRX) stake by 3.4% in Q2 2026, selling an estimated $21K and leaving 78,218 shares worth $685K. The position accounts for 0.01% of the portfolio, ranked #1199.

INTECH Investment Management first reported a position in IBRX in Q3 2024 and has held it in 8 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • INTECH Investment Management held 78,218 shares of ImmunityBio worth $685K as of Q2 2026.
  • INTECH Investment Management sold 2,770 ImmunityBio shares in Q2 2026, an estimated $21K.
  • ImmunityBio made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1199 holding.
  • INTECH Investment Management first reported a position in ImmunityBio in Q3 2024 and has held it in 8 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.